60 Degrees Pharmaceuticals, Inc. financial data

Symbol
SXTP, SXTPW on Nasdaq
Industry
Pharmaceutical Preparations
Location
1025 Connecticut Avenue Nw, Suite 1000, Washington, DC
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 364 %
Quick Ratio 25.2 %
Return On Equity -29.4 %
Return On Assets -21.2 %
Operating Margin -2.14K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.77M shares
Common Stock, Shares, Outstanding 1.02M shares -57.2%
Entity Public Float 11.6M USD
Common Stock, Value, Issued 102 USD -57.1%
Weighted Average Number of Shares Outstanding, Basic 1.01M shares +412%
Weighted Average Number of Shares Outstanding, Diluted 1.01M shares +412%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 418K USD +110%
Cost of Revenue 372K USD -51.3%
Research and Development Expense 3.8M USD +1418%
General and Administrative Expense 5.21M USD +144%
Operating Income (Loss) -8.94M USD -432%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.62M USD -24.8%
Income Tax Expense (Benefit) 625 USD +595%
Net Income (Loss) Attributable to Parent -1.57M USD -25.1%
Earnings Per Share, Basic 12.8 USD/shares +74.9%
Earnings Per Share, Diluted 12.8 USD/shares +74.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.58M USD
Accounts Receivable, after Allowance for Credit Loss, Current 296K USD +136%
Inventory, Net 426K USD -8.48%
Assets, Current 3.76M USD -33.7%
Property, Plant and Equipment, Net 160K USD +2028%
Operating Lease, Right-of-Use Asset 13.5K USD +6.88%
Intangible Assets, Net (Excluding Goodwill) 250K USD +21.2%
Other Assets, Noncurrent 405K USD
Assets 4.33M USD -41.2%
Liabilities, Current 1.22M USD -95.8%
Liabilities 1.37M USD -95.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 135K USD +87.1%
Retained Earnings (Accumulated Deficit) -36.3M USD -4.52%
Stockholders' Equity Attributable to Parent 3.04M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.96M USD
Liabilities and Equity 4.33M USD -41.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.14M USD -176%
Net Cash Provided by (Used in) Financing Activities 1.9M USD +944%
Net Cash Provided by (Used in) Investing Activities -9.81K USD -198%
Common Stock, Shares Authorized 150M shares
Common Stock, Shares, Issued 1.02M shares -57.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 752K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.58M USD +8167%
Deferred Tax Assets, Valuation Allowance 3.04M USD -8.85%
Deferred Tax Assets, Gross 3.74M USD +12.1%
Operating Lease, Liability 26.8K USD
Depreciation 9.3K USD -77.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.51M USD -25%
Lessee, Operating Lease, Liability, to be Paid 13.7K USD
Property, Plant and Equipment, Gross 299K USD +102%
Operating Lease, Liability, Current 529K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 14K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 14K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14K USD
Deferred Tax Assets, Operating Loss Carryforwards 3.45M USD +3.43%
Preferred Stock, Shares Issued 78.8K shares
Preferred Stock, Shares Authorized 1M shares 0%
Additional Paid in Capital 29.4M USD +137%
Preferred Stock, Shares Outstanding 78.8K shares
Amortization of Intangible Assets 9.47K USD +57.4%
Deferred Tax Assets, Net of Valuation Allowance 699K USD
Share-based Payment Arrangement, Expense 2.75M USD +888%
Interest Expense 2.29M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%